Mucosal-associated invariant T (MAIT) cells are an innate-like T cell subset, restricted by the nonclassic MHC class I-related protein MR1 and enriched at mucosal sites. Human studies have shown an association between MAIT cells and pathogen-specific antibody responses. In this study, we investigate the effect of human MAIT cells on B cells ex vivo. We found that supernatants from microbe-or cytokine-stimulated MAIT cells, when added to purified autologous B cells, increase frequencies of plasmablasts and promote IgA, IgG, and IgM production. We found effects to be mostly MR1-dependent and that the increases in plasmablasts are likely a result of increased differentiation from memory B cells. Furthermore, microbe-activated MAIT cell supernatant contains multiple cytokines known to stimulate B cells, including IL-6, -10, and -21. This study thus provides the first direct evidence of a newly identified role of MAIT cells in providing help to B cells.
Introduction
To elicit effective antibody responses to pathogens and differentiate into a mature phenotype, B cells frequently require the help of T cells to provide secondary signals. T follicular helper cells are one of the most commonly recognized T cell subsets to become B cell helpers [1] ; however, other T cell subsets, such as invariant natural killer T (iNKT) cells, have been shown to play a similar role, through both cognate and noncognate interactions with B cells [2] .
Mucosal associated invariant T (MAIT) cells are a recently described subset of innate-like T cells that, similar to iNKT cells, use a semi-invariant TCR to recognize nonpeptide bacteriaderived ligands presented on the surface of nonclassic MHC molecules [3] . MAIT cells account for ;5% of T cells in healthy humans [4] and are restricted by the nonpolymorphic MHCrelated protein MR1, which presents intermediates of the riboflavin synthesis pathway common to several microorganisms [3] . The MAIT cell TCR is most commonly composed of an invariant TCR V a chain (TCR-a variable; TRAV1-2, alternatively referred to as Va 7.2) paired with semi-invariant J a and more variable b chains [5] [6] [7] . MAIT cells express CD161, an NKassociated receptor, and in response to MR1-dependent activation are known to produce IFN-g, TNF-a, IL-17, and granzyme b [8, 9] . In addition, MAIT cells are capable of MR1-independent responses to several cytokines, including IL-2, -7, -12, -15, and -18 [10] [11] [12] .
Although B cells have been shown to modulate MAIT cell responses [13] , the ability of MAIT cells to stimulate B cell responses has not been investigated. Several observations in human studies suggest that MAIT cells may be B cell helpers. We have observed that in acute Vibrio cholerae infection, V. cholerae LPS-specific IgA and IgG antibody responses correlate positively with changes in MAIT cell frequencies [14] . In addition, Le Bourhis et al. [15] showed that in humans vaccinated orally with an attenuated Shigella dysenteriae strain, elevated MAIT cell frequencies and MAIT cell activation markers were associated with a significant Shigella LPSspecific antibody-secreting cell response. Finally, activated MAIT cells have been shown to produce sCD40L [16] , a key factor involved in T cell effects on B cells. However, there remains a lack of investigation into the ability of MAIT cells to provide help to B cells.
In this study, we examine the ability of human MAIT cells to stimulate B cell antibody production ex vivo. We activated MAIT cells with microbial, direct TCR, and cytokine stimulation, and the resulting supernatant was applied to purified autologous B cells and assayed for B cell stimulatory cytokines. This study provided the first direct evidence that MAIT cells induce B cell plasmablast differentiation and antibody production, a potentially important function of MAIT cells in the defense against microbial invasion.
MATERIALS AND METHODS

Primary cells for ex vivo studies
We obtained blood for this study from same-day discarded leukocyte filtration packs obtained from healthy anonymous blood donors, and isolated PBMCs 
Cytometric bead array
We measured the cytokine levels (IL-2, -4, -5, -6, -9, -10, -13, -17A, -17F, -21, and -22; TNF-a; and IFN-g) in activated MAIT cell supernatant with the Legendplex Human Th Cytokine Panel (BioLegend), according to the manufacturer's instructions and analyzed the data with Legendplex software (BioLegend). Where cytokine levels were too low to compute values, 1 pg/ml was used.
Flow cytometry
We ran flow cytometry of MAIT and B cell cocultures after 7 d of coculture on a BD Fortessa, using a panel consisting of CD3 APC-e780, CD19 PerCP-Cy5. 
Statistical analysis
We performed statistics and generated figures with Prism ver. 6.07 (GraphPad Software, La Jolla, CA, USA), comparing differences between groups using the Mann-Whitney U test, 1-way ANOVA followed by Tukey's multiplecomparisons test, or 2-way ANOVA followed by Fisher's LSD test, as indicated.
RESULTS
Activation of MAIT cells by APC/E. coli ex vivo induces IFN-g and TNF-a
MAIT cells are known to be activated by an intermediate of the riboflavin synthesis pathway that is present in many bacterial and fungal species [3] . For E. coli stimulation of MAIT cells, we used a strain of E. coli deficient in the RibA gene (BSV18), which prevents downstream synthesis of the MAIT ligand [18] . As a positive control, we also used strain 1100-2 (the RibA nonmutant strain upon which BSV18 is based) and BL21, a wild-type E. coli strain which has been shown to result in high levels of MAIT-cell activation [19] . , a phenotype that corresponds to plasma cells [20] . Supernatant from THP-1 cells stimulated with BL21 in the absence of MAIT cells (THP-1/BL21) did have a modest effect on B cell plasmablast frequency (;1% CD38 ++ CD24 2 ) (Fig. 2D ), but this was still significantly lower than when MAIT cells were present. Thus, factors released by E. coli-stimulated MAIT cells appear to be responsible for the increased B cell plasmablast frequency.
Given that MAIT cells are stimulated via their TCR through interaction with MR1 expressed on APCs, we wanted to know whether blockade of MR1 would decrease MAIT-mediated stimulation of B cells. When the MR1-blocking antibody was added to the MAIT/THP-1/E. coli stimulation, addition of the supernatant to B cells resulted in significantly lower B cell plasmablast frequency (Fig. 2G) . MAIT cells are also thought to be stimulated by IL-12 and IL-18 secreted by APCs [12] ; however, addition of IL-12 and -18 blocking antibodies to the MAIT/THP-1 E. coli coculture did not result in reduced plasmablast frequency. Combinations of MR1 and IL-12/18 blockade did not seem to have an additive effect on decreasing plasmablast frequency. Thus, MAIT TCR stimulation seems to be critical for the ability of MAIT cells to provide help to B cells.
To confirm the need for TCR stimulation of MAIT cells, we also exposed MAIT/THP-1 cocultures to BSV18, a strain of E. coli that is defective for the RibA gene and thus lacks the ability to synthesize the MAIT ligand [18] , as well as strain 1100-2, the congenic strain for BSV18 that is not defective in RibA (Fig. 2H) . Addition of MR1 blocking antibodies reduced the B cell plasmablast frequency induced by MAIT/THP-1/ 1100-2 supernatant. Addition of MAIT/THP-1/BSV18 supernatant, however, resulted in no changes in plasmablast frequency between MR1 blockade and no-blockade conditions. Thus, B cell differentiation induced by activated MAIT cells is dependent on TCR stimulation.
Supernatant from MAIT cells and APC incubated with E. coli stimulates B cell antibody production Next, we measured IgA, IgG, and IgM levels in supernatant from B cells stimulated with MAIT/THP-1/BL21 supernatant by ELISA. As MAIT cells stimulated with strain BL21 resulted in more potent B cell stimulatory responses than strain 1100-2 for undetermined reasons, BL21 was used for the remainder of MAIT/B cell experiments. Supernatant from MAIT/THP-1/BL21 coculture stimulated B cells to produce significantly higher levels of IgA, IgG, and IgM, compared to either MAIT/THP-1 supernatant, without BL21, or THP-1 alone, with BL21 (Fig. 3) . The antibodies produced were not, however, LPS-specific, as seen by LPS ELISA (data not shown). As seen with B cell plasmablast expansion, blockade of MR1 during the MAIT/THP-1/BL21 stimulation resulted in decreased antibody levels, similar to those seen for the MAIT/THP-1 no stimulation or THP-1 only with BL21 conditions. Also similar to the B cell phenotype results, IL-12 and -18 blockade during MAIT/THP-1/BL21 stimulation failed to result in significant decreases in B cell antibody production. When we added anti-CD40L blocking antibody to MAIT/THP-1/BL21 supernatant, no significant decrease in IgA, IgG, or IgM levels were seen, thus CD40L produced by MAIT cells does not appear to be required for MAIT-mediated help for B cells. 
TCR-and cytokine-stimulated MAIT cells promote increased B cell plasmablast frequency and antibody production
We tested various combinations of cytokines for their ability to stimulate MAIT cells to induce B cell differentiation and antibody production in coculture of purified Va7. Data shown are mean 6 SEM, and significance was determined by 1-way ANOVA using Tukey's multiple comparisons test. Data are representative of 2 independent experiments. *P # 0.05; **P # 0.01; ***P # 0.001; ****P # 0.00001. CD3/anti-CD28 antibodies (TCR stimulation), IL-12/IL-18, or both TCR and IL-12/18 stimulation (Fig. 4E-H) . Supernatant tested for antibodies by ELISA revealed that supernatant from MAIT cells stimulated with anti-CD3/CD28 or anti-CD3/CD28 and IL-12/18 induced IgA, IgG, and IgM secretion (Fig. 4E-G) . In addition, supernatant from MAIT cells stimulated with anti-CD3/CD28, and particularly anti-CD3/CD28 stimulation with exogenous IL-12/18, induced greatly increased plasmablast frequencies (Fig. 4H) . This is in agreement with findings from Slichter et al. [21] in which TCR and inflammatory signals synergize to elicit potent effector function in MAIT cells. Thus, secreted factors from TCR-and cytokine-activated MAIT cells, in the absence of other cell types such as THP-1, are capable of providing help to B cells.
Memory B cells differentiate into plasmablasts after stimulation with MAIT/THP-1/BL21 supernatant
To determine whether activated MAIT cell supernatant drives B cell differentiation into plasmablasts, or whether it merely induces expansion and/or survival of preexisting plasma cell or plasmablast populations, we sorted B cells into 4 (Fig. 5A) . Either naive B cells alone or naive B cells plus the different B cell populations were cultured with activated MAIT cell supernatant. Sorted naive B cells were included in each condition to ensure a sufficient number of cells present per well to facilitate survival and staining efficacy for flow cytometry. Purified naive B cells exposed to MAIT/THP-1/BL21 supernatant did not generate plasmablasts (Fig. 5B) . However, when both switched and nonswitched CD27 + memory CD38 2 B cells were exposed to MAIT/THP-1/BL21 supernatant, there was a marked expansion of CD38 ++ CD24 2 plasmablasts (Fig. 5C and D) . These cells were not present at the beginning of culture, nor did they expand with either THP-1/BL21 supernatant or medium alone, indicating that MAIT-specific factors induced plasmablast differentiation. Addition of anti-MR1 during the MAIT/THP-1/BL21 coculture resulted in a significant decrease in the ability of supernatant to induce plasmablast differentiation. IgD APC/E. coli-stimulated MAIT cells produce multiple B cell stimulatory factors
As supernatant from MAIT cells cocultured with THP-1 cells and stimulated with fixed E. coli was found to stimulate B cell differentiation and antibody production, we wanted to know which specific soluble factors contribute to this effect. We measured 13 different cytokine concentrations in primary MAIT cell supernatant by multiplex cytokine array using a T-helper-specific panel (Fig. 6) . 
DISCUSSION
Recent studies have revealed that subsets of innate lymphocytes, such as iNKT cells [22] and gd T cells [23] , have the capacity to become B cell helpers. In this report, we provide evidence to Figure 6 . Cytokine profile of ex vivo-stimulated MAIT cells. Va7.2 + primary T cells from multiple subjects were cultured overnight with THP-1 cells in the presence or absence of fixed E. coli (strain BL21) at an MOI of 100 per THP-1 cell and with or without anti-MR1 (10 mg/ml) and cytokine levels were measured with a T-helper-specific multiplex cytokine array. Data shown are means 6 SEM, significance was determined by Mann-Whitney U tests and are representative of 2 independent experiments. **P # 0.01; ***P # 0.001.
suggest that MAIT cells have the capacity for B cell help, through increasing plasmablasts and promoting Ig production in an MR1-dependent manner, likely by increasing differentiation from memory B cells.
Previous studies have shown that B cells are capable of modulating MAIT cell responses [13] , and B cells have been shown to be essential to the formation of MAIT cells in mice [8] , with their accumulation in the gut being dependent on MR-1-expressing B cells [24] , although B cells were not found to be essential for MAIT cell development in humans [25] . Because of the ex vivo nature of our experiments, we are unable to determine the in vivo location and context in which MAIT and B cells potentially interact to provide the necessary help to B cells. We failed to detect CXCR5 expression in either activated or nonactivated MAIT cells (data not shown), and it is unclear whether MAIT cells provide help to B cells within germinal centers, as is the case with follicular T-helper cells, or at extrafollicular sites. Given that MAIT cells represent up to 40% of liver lymphocytes [26] , that the liver receives the majority of its blood supply from the gastrointestinal tract (thus acting as a sentinel site for gut flora), and in light of recent work identifying the liver as a site of IgA production by B cells [27] , it is possible that MAIT cell stimulation of B cells may occur in the liver.
Human MAIT cells have been shown to upregulate factors known to have B cell stimulatory ability in response to bacterial stimulation, including IL-4, -5, -10, and -13 and CD40L [16, 28] . In our experiments, we observed production of IL-2, -6, -10, and -21 in cocultures of MAIT cells with E. coli and THP-1 cells. Several of these upregulated cytokines are known to promote B cell differentiation and antibody production. IL-2 is known to induce B cell differentiation and proliferation [29] . IL-6 is known to induce greatly elevated levels of IgG [30] . IL-10 can enhance B cell survival, proliferation, and antibody production [31] . IL-21 is well recognized for its ability to promote B cell proliferation, plasma cell differentiation, and antibody production [32] . IFN-g enhances antibody production and entry into the S phase in human B cells [33] , and TNF-a may provide costimulation in mitogen-activated B cells [34] . Clearly, there are many factors in activated MAIT cell supernatant that may be responsible for MAIT-mediated B cell differentiation and antibody production. Further studies are needed to determine the specific mechanism(s) responsible for these effects.
The generation of antibodies by B cells is critical for the development of protective immunity against pathogens. A large body of literature has implicated T cells, in particular Tfh cells, in mediating the process of affinity maturation and isotyping switching [1] . More recent work on iNKT cells has also described their role in providing both cognate and noncognate help to B cells [2] . In this report, we demonstrate a newlydescribed ability of MAIT cells to provide help to B cells ex vivo. Given their relative abundance in humans (;5% of circulating T cells) compared to that of iNKT and Tfh cells, and although further studies are needed to demonstrate the in vivo relevance of these findings, our data suggest that MAIT cells may be a potential target for improving B cell responses in humans and may be useful for reactivation and differentiation of memory B cells. 
